ALERE INC., as Issuer, the GUARANTORS named herein, as Guarantors, and U.S. BANK NATIONAL ASSOCIATION, as Trustee SIXTEENTH SUPPLEMENTAL INDENTURE Dated as of May 24, 2013 6.500% Senior Subordinated Notes due 2020Supplemental Indenture • May 30th, 2013 • Alere Inc. • In vitro & in vivo diagnostic substances • New York
SIXTEENTH SUPPLEMENTAL INDENTURE, dated as of May 24, 2013 (this “Supplemental Indenture”), among Alere Inc. (formerly Inverness Medical Innovations, Inc.), a Delaware corporation, as Issuer (the “Issuer”), each of the Guarantors named herein, as Guarantors, and U.S. Bank National Association, a national banking association, as Trustee (the “Trustee”).
REGISTRATION RIGHTS AGREEMENT Dated as of May 24, 2013 By and Among ALERE INC., the GUARANTORS named herein and GOLDMAN, SACHS & CO., JEFFERIES LLC and CREDIT SUISSE SECURITIES (USA) LLC, as Representatives of the several Initial PurchasersRegistration Rights Agreement • May 30th, 2013 • Alere Inc. • In vitro & in vivo diagnostic substances • New York
This Registration Rights Agreement (this “AGREEMENT”) is dated as of May 24, 2013, by and among ALERE INC., a Delaware corporation (the “COMPANY”), and each of the Guarantors (as defined herein) (the Company and the Guarantors are referred to collectively herein as the “ISSUERS”), on the one hand, and, GOLDMAN, SACHS & CO., JEFFERIES LLC and CREDIT SUISSE SECURITIES (USA) LLC (collectively, the “REPRESENTATIVES”), as representatives of the several Initial Purchasers named on Schedule A of the Purchase Agreement (the “PURCHASE AGREEMENT”), dated as of May 13, 2013, by and among the Issuers and such Initial Purchasers (the “INITIAL PURCHASERS”), on the other hand.
